Cited by 6,661SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.

Virological assessment of hospitalized patients with COVID-2019

Open access

Wölfel, Roman, Corman, Victor M., Guggemos, Wolfgang, Seilmaier, Michael, Zange, Sabine, Müller, Marcel A., Niemeyer, Daniela, Jones, Terry C., Vollmar, Patrick, Rothe, Camilla, Hoelscher, Michael, Bleicker, Tobias, Brünink, Sebastian, Schneider, Julia, Ehmann, Rosina, Zwirglmaier, Katrin, Drosten, Christian, Wendtner, Clemens·2020·Nature

DOI 10.1038/s41586-020-2196-x

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in late 2019 1,2. Initial outbreaks in China involved 13.8% of cases with severe courses, and 6.1% of cases with critical courses 3. This severe presentation may result from the virus using a virus receptor that is expressed predominantly in the lung 2,4; the same receptor tropism is thought to have determined the pathogenicity-but also aided in the control-of severe acute respiratory syndrome (SARS) in 2003 5. However, there are reports of cases of COVID-19 in which the patient shows mild upper respiratory tract symptoms, which suggests the potential for pre- or oligosymptomatic transmission 6-8. There is an urgent need for information on virus replication, immunity and infectivity in specific sites of the body. Here we report a detailed virological analysis of nine cases of COVID-19 that provides proof of active virus replication in tissues of the upper respiratory tract. Pharyngeal virus shedding was very high during the first week of symptoms, with a peak at 7.11 × 10 8 RNA copies per throat swab on day 4. Infectious virus was readily isolated from samples derived from the throat or lung, but not from stool samples-in spite of high concentrations of virus RNA. Blood and urine samples never yielded virus. Active replication in the throat was confirmed by the presence of viral replicative RNA intermediates in the throat samples. We consistently detected sequence-distinct virus populations in throat and lung samples from one patient, proving independent replication. The shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (and by day 14 in all patients), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild illness of the upper respiratory tract. The confirmation of active virus replication in the upper respiratory tract has implications for the containment of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2196-x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Self-citation
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Self-citation
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. W., Bleicker, T., Brünink, S., Schneider, J. A., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,266
Self-citation
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Self-citation
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Jänke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,211
Self-citation

Show all 37 references

Sorted by citations

Items 401–500 of 1,012

Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
Bohn, M. K., Lippi, G., Horvath, A. R., Sethi, S. K., Koch, D. D., Ferrari, M., Wang, C.-B., Mancini, N., Steele, S., & Adeli, K. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0722 · Cited by 190
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Cicco, S., Cicco, G., Racanelli, V., & Vacca, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/7527953 · Cited by 195
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response
Goyal, A., Ojeda, E. F. C., Fabian, E., & Schiffer, J. T. (2020) · Science Advances · doi:10.1126/sciadv.abc7112 · Cited by 187
Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms
Argyropoulos, K. V., Serrano, A., Hu, J., Black, M. A., Feng, X., Shen, G., Call, M., Kim, M. J., Lytle, A. G., Belovarac, B., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.07.001 · Cited by 191
Retracted
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
Marklund, E., Leach, S., Axelsson, H., Nyström, K., Norder, H., Bemark, M., Angeletti, D., Lundgren, A., Nilsson, S., Andersson, L., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241104 · Cited by 194
COVID-19 pandemic and its positive impacts on environment: an updated review
Khan, I., Shah, D., & Shah, D. (2020) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-020-03021-3 · Cited by 188
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
Weigang, S., Fuchs, J., Zimmer, G., Schnepf, D., Kern, L., Beer, J., Luxenburger, H., Ankerhold, J., Falcone, V., Kemming, J. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26602-3 · Cited by 184
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID‐19
Hur, K., Price, C. P. E., Gray, E., Gulati, R. K., Maksimoski, M. T., Racette, S. D., Schneider, A. L., & Khanwalkar, A. R. (2020) · Otolaryngology · doi:10.1177/0194599820929640 · Cited by 187
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test
An, J., Liao, X., Xiao, T., Qian, S., Yuan, J., Ye, H., Qi, F., Shen, C., Wang, L., Liu, Y., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5602 · Cited by 187
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection
Diao, B., Wen, K., Zhang, J., Chen, J., Han, C. Q., Chen, Y., Wang, S., Deng, G., Zhou, H., & Wu, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.057 · Cited by 187
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
Nissen, K., Krambrich, J., Akaberi, D., Hoffman, T., Ling, J., Lundkvist, Å., Svensson, L., & Salaneck, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-76442-2 · Cited by 184
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
Boucau, J., Marino, C., Regan, J., Uddin, R., Choudhary, M. C., Flynn, J. P., Chen, G., Stuckwisch, A. M., Mathews, J., Liew, M. Y., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2202092 · Cited by 186
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
Schütz, D., Ruiz‐Blanco, Y. B., Münch, J., Kirchhoff, F., Sánchez‐García, E., & Müller, J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.007 · Cited by 180
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
Truong, T., Ryutov, A., Pandey, U., Yee, R., Goldberg, L., Bhojwani, D., Aguayo-Hiraldo, P. I., Pinsky, B. A., Pekosz, A. S., Shen, L., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103355 · Cited by 177
“…sequence and reverse primer and probe complementary to E gene sequences was adapted from Wolfel et al . and combined in multiplex with the Hong Kong Orf1ab and Centers for Disease Control and Prevention RNAse P primer/probe sets [19,20]. as an additional biomarker for actively replicating virus.”
Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting
Paulos, A. P., Fuhrmeister, E. R., Cantrell, M. E., Pitol, A. K., Swarthout, J. M., Powers, J. E., Nadimpalli, M. L., Julian, T. R., & Pickering, A. J. (2020) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.0c00875 · Cited by 187
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021)
Hanson, K. E., Caliendo, A. M., Arias, C. A. D., Hayden, M. K., Englund, J. A., Lee, M. J., Loeb, M. B., Patel, R., Alayli, A. E., Altayar, O., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab048 · Cited by 184
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
Kim, K. S., Ejima, K., Iwanami, S., Fujita, Y., Ohashi, H., Koizumi, Y., Asai, Y., Nakaoka, S., Watashi, K., Aihara, K., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001128 · Cited by 180
“To determine when to end isolation, it is frequently necessary to have a negative PCR test as well as disappearance of symptoms [14].”
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Essalmani, R., Jain, J., Susan‐Resiga, D., Andréo, U., Evagelidis, A., Derbali, R. M., Huynh, D. N., Dallaire, F., Laporte, M., Delpal, A., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00128-22 · Cited by 194
SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance
Kutter, J. S., de Meulder, D., Bestebroer, T. M., Lexmond, P., Mulders, A., Richard, M., Fouchier, R. A. M., & Herfst, S. (2021) · Nature Communications · doi:10.1038/s41467-021-21918-6 · Cited by 176
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
Loeffelholz, M. J., Alland, D., Butler‐Wu, S. M., Pandey, U., Perno, C. F., Nava, A., Carroll, K. C., Mostafa, H. H., Davies, E. A., McEwan, A. K., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00926-20 · Cited by 180
Post-viral effects of COVID-19 in the olfactory system and their implications
Xydakis, M. S., Albers, M. W., Holbrook, E. H., Lyon, D. M., Shih, R., Frasnelli, J., Pagenstecher, A., Kupke, A., Enquist, L. W., & Perlman, S. M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00182-4 · Cited by 195
Rapid Diagnostic Testing for SARS-CoV-2
Drain, P. K. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2117115 · Cited by 185
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., Avanzato, V., Bushmaker, T., Flaxman, A., Ulaszewska, M., et al. (2020) · doi:10.1101/2020.05.13.093195 · Cited by 246
Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados
Iser, B. P. M., Sliva, I., Raymundo, V. T., Poleto, M. B., Schuelter‐Trevisol, F., & Bobinski, F. (2020) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742020000300018 · Cited by 256
Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses
Mick, E., Kamm, J., Pisco, A. O., Ratnasiri, K., Babik, J. M., Castañeda, G. R., DeRisi, J. L., Detweiler, A. M., Hao, S. L., Kangelaris, K. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19587-y · Cited by 176
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Triggle, C. R., Bansal, D., Ding, H., Islam, M. M., Farag, E., Hadi, H. A., & Sultan, A. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631139 · Cited by 187
“8% for both or either, or IgM or IgG, respectively (63, 129).”
Background
Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology
LaTurner, Z. W., Zong, D. M., Kalvapalle, P. B., Gamas, K. R., Terwilliger, A. L., Crosby, T., Ali, P., Avadhanula, V., Santos, H. H., Weesner, K., et al. (2020) · Water Research · doi:10.1016/j.watres.2021.117043 · Cited by 178
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Vanshylla, K., Di Cristanziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.015 · Cited by 153
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease
Anderson, D. E., Sivalingam, V., Kang, A. E. Z., Ananthanarayanan, A., Arumugam, H., Jenkins, T. M., Hadjiat, Y., & Eggers, M. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00316-3 · Cited by 177
Management strategies in a SEIR-type model of COVID 19 community spread
Rǎdulescu, A., Williams, C., & Cavanagh, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-77628-4 · Cited by 212
Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum
Li, J., & Lillehoj, P. B. (2021) · ACS Sensors · doi:10.1021/acssensors.0c02561 · Cited by 177
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Ku, Z., Xie, X., Hinton, P. R., Liu, X., Ye, X., Muruato, A. E., Ng, D., Biswas, S., Zou, J., Liu, Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03673-2 · Cited by 170
Covid-19: should the public wear face masks?
Javid, B., Weekes, M. P., & Matheson, N. J. (2020) · BMJ · doi:10.1136/bmj.m1442 · Cited by 178
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
Moll, G., Drzeniek, N. M., Kamhieh‐Milz, J., Geißler, S., Volk, H., & Reinke, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01091 · Cited by 176
Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR
Park, M., Won, J., Choi, B. Y., & Lee, C. J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0452-7 · Cited by 176
Review of indoor aerosol generation, transport, and control in the context of COVID‐19
Kohanski, M. A., Lo, L. J., & Waring, M. S. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22661 · Cited by 180
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2
Körner, R. W., Majjouti, M., Alcazar, M. A. A., & Mahabir, E. (2020) · Viruses · doi:10.3390/v12080880 · Cited by 184
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
Lu, J., Peng, J.-J., Xiong, Q.-L., Liu, Z., Lin, H.-F., Tan, X.-H., Kang, M., Yuan, R.-Y., Zeng, L., Zhou, P., et al. (2020) · medRxiv · doi:10.1016/j.ebiom.2020.102960 · Cited by 167
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Gremmels, H., Winkel, B. M. F., Schuurman, R., Rosingh, A., Rigter, N. A. M., Rodriguez, O., Ubijaan, J., Wensing, A. M. J., Bonten, M. J. M., & Hofstra, L. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100677 · Cited by 179
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
Ke, R., Zitzmann, C., Ho, D. D., Ribeiro, R. M., & Perelson, A. S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111477118 · Cited by 175
“First, the data we used for model inference were from infected individuals with relatively mild or no symptoms (3, 20), who rapidly cleared the virus.”
Influential
Heat inactivation of the severe acute respiratory syndrome coronavirus 2
Batéjat, C., Grassin, Q., Manuguerra, J., & Leclercq, I. (2021) · Journal of Biosafety and Biosecurity · doi:10.1016/j.jobb.2020.12.001 · Cited by 171
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
Parkins, M. D., Lee, B. E., Acosta, N., Bautista, M. A., Hubert, C. R. J., Hrudey, S. E., Frankowski, K., & Pang, X. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-22 · Cited by 189
The duration of infectiousness of individuals infected with SARS-CoV-2
Walsh, K. A., Spillane, S., Comber, L., Cardwell, K., Harrington, P., Connell, J., Teljeur, C., Broderick, N., de Gascun, C. F., Smith, S. M., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.10.009 · Cited by 157
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
Aguiar, J. A., Tremblay, B. J.-M., Mansfield, M. J., Woody, O. Z., Lobb, B., Banerjee, A., Chandiramohan, A., Tiessen, N., Cao, Q., Dvorkin‐Gheva, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01123-2020 · Cited by 180
Individual Differences, Economic Stability, and Fear of Contagion as Risk Factors for PTSD Symptoms in the COVID-19 Emergency
Crosta, A. D., Palumbo, R., Marchetti, D., Ceccato, I., Malva, P. L., Maiella, R., Cipi, M., Roma, P., Mammarella, N., Verrocchio, M. C., et al. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.567367 · Cited by 188
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
Rocco, P. R. M., Silva, P. L., Cruz, F. F., Melo-Junior, M. A. C., Tierno, P. F. G. M. M., Moura, M. A., Oliveira, L. F. G. D., Lima, C. C., dos Santos, E. A., Junior, W. F., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.03725-2020 · Cited by 173
“This effect may have epidemiological impact, potentially decreasing community spread of SARS-CoV-2 [9, 10], morbidity [11] and mortality [12].”
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step
Bruce, E. A., Huang, M.-L. W., Perchetti, G. A., Tighe, S. W., Laaguiby, P., Hoffman, J. J., Gerrard, D. L., Nalla, A. K., Wei, Y., Greninger, A. L., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000896 · Cited by 172
Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19
Fenollar, F., Bouam, A., Ballouche, M., Fuster, L., Prudent, E., Colson, P., Tissot‐Dupont, H., Million, M., Drancourt, M., Raoult, D., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02589-20 · Cited by 172
Making waves: Plausible lead time for wastewater based epidemiology as an early warning system for COVID-19
Bibby, K. J., Bivins, A. W., Wu, Z., & North, D. (2021) · Water Research · doi:10.1016/j.watres.2021.117438 · Cited by 172
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2
Meister, T. L., Brüggemann, Y., Tödt, D., Conzelmann, C., Müller, J. A., Groß, R. M., Münch, J., Krawczyk, A., Steinmann, J., Steinmann, J., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa471 · Cited by 172
Modeling the viral dynamics of SARS-CoV-2 infection
Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 173
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys
Speranza, E. E., Williamson, B. N., Feldmann, F., Sturdevant, G. L., Pérez-Pérez, L., Meade-White, K. D., Smith, B. J., Lovaglio, J., Martens, C., Munster, V. J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe8146 · Cited by 160
Emerging SARS-CoV-2 variants expand species tropism to murines
Shuai, H., Chan, J. F., Yuen, T. T., Yoon, C., Hu, J., Wen, L., Hu, B., Yang, D., Wang, Y., Hou, Y., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103643 · Cited by 166
An enhanced isothermal amplification assay for viral detection
Qian, J., Boswell, S. A., Chidley, C., Lu, Z., Pettit, M. E., Gaudio, B. L., Fajnzylber, J. M., Ingram, R. T., Ward, R. H. R., Li, J. Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19258-y · Cited by 170
Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks
Zhu, Y., Oishi, W., Maruo, C., Saito, M., Chen, R., Kitajima, M., & Sano, D. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145124 · Cited by 170
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
Lopes‐Pacheco, M., Silva, P. L., Cruz, F. F., Battaglini, D., Robba, C., Pelosi, P. P., Morales, M. M., Neves, C. C., & Rocco, P. R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.593223 · Cited by 178
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Sokołowska, M., Łukasik, Z. M., Agache, I. O., Akdiş, C. A., Akdiş, D., Akdiş, M., Barcik, W., Brough, H. A., Eiwegger, T., Eljaszewicz, A., et al. (2020) · Allergy · doi:10.1111/all.14462 · Cited by 170
Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
Gniazdowski, V., Morris, C. P., Wohl, S., Mehoke, T. S., Ramakrishnan, S., Thielen, P., Powell, H. R., Smith, B., Armstrong, D. T., Herrera, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1616 · Cited by 171
Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection
O’Donnell, V. B., Thomas, D. W., Stanton, R. J., Maillard, J., Murphy, R. C., Jones, S. A., Humphreys, I. R., Wakelam, M. J. O., Fegan, C., Wise, M. P., et al. (2020) · Function · doi:10.1093/function/zqaa002 · Cited by 167
Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea
Han, M. S., Seong, M., Kim, N., Shin, S., Cho, S. I., Park, H., Kim, T. S., Park, S. S., & Choi, E. H. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.202449 · Cited by 168
Review of Current Advances in Serologic Testing for COVID-19
Freire, A. P. E., Akgun, Y., Mana, A. F. A., Tjendra, Y., Millan, N. C., Gomez-Fernandez, C. R., & Cray, C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa112 · Cited by 170
The geography of COVID-19 spread in Italy and implications for the relaxation of confinement measures
Bertuzzo, E., Mari, L., Pasetto, D., Miccoli, S., Casagrandi, R., Gatto, M., & Rinaldo, A. (2020) · Nature Communications · doi:10.1038/s41467-020-18050-2 · Cited by 165
Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors
Peinetti, A. S., Lake, R. J., Cong, W., Cooper, L. M., Wu, Y., Ma, Y., Pawel, G. T., Toimil‐Molares, M. E., Trautmann, C., Rong, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2848 · Cited by 173
Profile of a killer: the complex biology powering the coronavirus pandemic
Cyranoski, D. (2020) · Nature · doi:10.1038/d41586-020-01315-7 · Cited by 170
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
Malik, Y. S., Kumar, N., Sircar, S., Kaushik, R., Bhat, S., Dhama, K., Gupta, P., Goyal, K., Singh, M. P., Ghoshal, U., et al. (2020) · Pathogens · doi:10.3390/pathogens9070519 · Cited by 165
Photocatalytic TiO2 nanomaterials as potential antimicrobial and antiviral agents: Scope against blocking the SARS-COV-2 spread
Prakash, J., Cho, J., & Mishra, Y. K. (2021) · Micro and Nano Engineering · doi:10.1016/j.mne.2021.100100 · Cited by 165
Prediction and analysis of Corona Virus Disease 2019
Yan, H., Xu, T., Hu, H., Wang, P., & Bai, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239960 · Cited by 167
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco
Pilarowski, G. O. W., Lebel, P. M., Sunshine, S., Liu, J., Crawford, E. D., Marquez, C., Rubio, L., Chamie, G., Martinez, J., Peng, J., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa802 · Cited by 160
“In the context of community based testing, we defined a threshold for high virus levels corresponding to the range of highest probability of transmissibility: a Ct of 30, which corresponds to a viral RNA copy number of approximately 1.9 × 10 4 in this assay [10, 13].”
Influential
Community Transmission of SARS-CoV-2 by Surfaces: Risks and Risk Reduction Strategies
Pitol, A. K., & Julian, T. R. (2021) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.0c00966 · Cited by 156
Patterns of within-host genetic diversity in SARS-CoV-2
Tonkin-Hill, G., Martincorena, I., Amato, R., Lawson, A. R. J., Gerstung, M., Johnston, I., Jackson, D. K., Park, N. R., Lensing, S. V., Quail, M. A., et al. (2021) · eLife · doi:10.7554/elife.66857 · Cited by 161
Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle
Bhowmick, G. D., Dhar, D., Nath, D., Ghangrekar, M. M., Banerjee, R., Das, S., & Chatterjee, J. (2020) · npj Clean Water · doi:10.1038/s41545-020-0079-1 · Cited by 163
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus
Andersson, M. I., Arancibia-Cárcamo, C. V., Auckland, K., Baillie, J. K., Barnes, E. J., Beneke, T., Bibi, S., Brooks, T. J. G., Carroll, M. W., Crook, D. W., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16002.2 · Cited by 163
Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
Zhang, F., Gan, R., Zhen, Z., Hu, X., Li, X., Zhou, F., Liu, Y., Chen, C., Xie, S., Zhang, B., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00263-y · Cited by 156
Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
Bunders, M. J., & Altfeld, M. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.003 · Cited by 167
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
Mallett, S., Allen, A. J., Graziadio, S., Taylor, S. A., Sakai, N. S., Green, K., Suklan, J., Hyde, C., Shinkins, B., Zhelev, Z., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01810-8 · Cited by 175
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review
Fricke, L. M., Glöckner, S., Dreier, M., & Lange, B. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.11.039 · Cited by 161
Breathing, speaking, coughing or sneezing: What drives transmission of SARS‐CoV‐2?
Stadnytskyi, V., Anfinrud, P., & Bax, A. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13326 · Cited by 177
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
Salton, F., Confalonieri, P., Meduri, G. U., Santus, P., Harari, S. A., Scala, R., Lanini, S., Vertui, V., Oggionni, T., Caminati, A., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa421 · Cited by 166
Detection and quantification of SARS-CoV-2 RNA in wastewater and treated effluents: Surveillance of COVID-19 epidemic in the United Arab Emirates
Hasan, S. W., Ibrahim, Y., Daou, M., Kannout, H., Jan, N., Lopes, Á., AlSafar, H. S., & Yousef, A. F. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.142929 · Cited by 161
Shedding of infectious SARS-CoV-2 despite vaccination
Riemersma, K. K., Haddock, L. A., Wilson, N. A., Minor, N. R., Eickhoff, J. C., Grogan, B., Kita-Yarbro, A., Halfmann, P., Segaloff, H. E., Kocharian, A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010876 · Cited by 169
“Previous studies focusing primarily on unvaccinated individuals suggested that RT-qPCR Ct values <25 may be strongly associated with the shedding of infectious SARS-CoV-2 [8,9].”
Background
Neuropathobiology of COVID-19: The Role for Glia
Tremblay, M.-E., Madore, C., Bordeleau, M., Tian, L., & Verkhratsky, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592214 · Cited by 159
Dental Care and Oral Health under the Clouds of COVID-19
Ren, Y., Rasubala, L., Malmström, H., & Eliav, E. (2020) · JDR Clinical & Translational Research · doi:10.1177/2380084420924385 · Cited by 161
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
Salguero, F. J., White, A., Slack, G. S., Fotheringham, S. A., Bewley, K. R., Gooch, K. E., Longet, S., Humphries, H. E., Watson, R. J., Hunter, L. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21389-9 · Cited by 163
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Achar, A., & Ghosh, C. (2020) · Cells · doi:10.3390/cells9112360 · Cited by 160
Efficient detection of SARS-CoV-2 RNA in the solid fraction of wastewater
KITAMURA, K., Sadamasu, K., Muramatsu, M., & Yoshida, H. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.144587 · Cited by 159
“It has also been reported that SARS-CoV-2-infected enterocytes from the small intestine, along with the virus, are shed through feces (Wolfel et al. 2020; Xu et al. 2020; Zhang et al. 2020).”
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died
Aschman, T., Schneider, J. A., Greuel, S., Meinhardt, J., Streit, S., Goebel, H., Büttnerova, I., Elezkurtaj, S., Scheibe, F., Radke, J., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2004 · Cited by 160
Self-citation
Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing
Liu, T., Liang, W., Zhong, H., He, J., Chen, Z., He, G., Song, T., Chen, S., Wang, P., Li, J., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1787799 · Cited by 158
SARS-CoV-2 in the environment: Modes of transmission, early detection and potential role of pollutions
Huraimel, K. A., Alhosani, M., Kunhabdulla, S., & Stietiya, M. H. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140946 · Cited by 154
SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations
Jayamohan, H., Lambert, C. J., Sant, H. J., Jafek, A. R., Patel, D., Feng, H., Beeman, M., Mahmood, T., Nze, U. C., & Gale, B. K. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02958-1 · Cited by 160
Testing for COVID-19: A way to lift confinement restrictions
OECD (2020) · OECD policy responses to coronavirus (Covid-19) · doi:10.1787/89756248-en · Cited by 158
COVID-19, SARS and MERS: A neurological perspective
Kwong, K. C. N. K., Mehta, P. R., Shukla, G., & Mehta, A. R. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.124 · Cited by 161
Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19
Golmai, P., Larsen, C. P., DeVita, M. V., Wahl, S. J., Weins, A., Rennke, H. G., Bijol, V., & Rosenstock, J. L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050683 · Cited by 156
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people
Hopkinson, N. S., Rossi, N., Moustafa, J. S. E.-S., Laverty, A. A., Quint, J. K., Freidin, M. B., Visconti, A., Murray, B. A. K., Marc Modat, A., Sebastien Ourselin, A., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216422 · Cited by 162
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
Chen, P., Bobrovitz, N., Premji, Z., Koopmans, M., Fisman, D. N., & Gu, F. (2021) · eLife · doi:10.7554/elife.65774 · Cited by 146
Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
Tiberghien, P., de Lamballerie, X. N., Morel, P., Gallian, P., Lacombe, K., & Yazdanpanah, Y. (2020) · Vox Sanguinis · doi:10.1111/vox.12926 · Cited by 155
Neuromechanisms of SARS-CoV-2: A Review
DosSantos, M. F. H., Devalle, S., Aran, V., Capra, D., Roque, N. R., Coelho‐Aguiar, J. D. M., Spohr, T. C. L. D. S. E., Subilhaga, J. G., Pereira, C. M., Meira, I. D., et al. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00037 · Cited by 158
Several forms of SARS-CoV-2 RNA can be detected in wastewaters: Implication for wastewater-based epidemiology and risk assessment
Wurtzer, S., Waldman, P., Ferrier-Rembert, A., Frénois-Veyrat, G., Mouchel, J., Boni, M., Maday, Y., Maréchal, V., & Moulin, L. (2021) · Water Research · doi:10.1016/j.watres.2021.117183 · Cited by 152
Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities
Yang, Q., Saldi, T. K., Gonzales, P. K., Lasda, E. L., Decker, C. J., Tat, K. L., Fink, M. R., Hager, C. R., Davis, J. C., Ozeroff, C. D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104547118 · Cited by 155
Immune responses during COVID-19 infection
Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 167
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Brunetta, E., Folci, M., Bottazzi, B., Santis, M. D., Gritti, G., Protti, A., Mapelli, S. N., Bonovas, S., Piovani, D., Leone, R., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00832-x · Cited by 156

Authors: Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brünink, S., Schneider, J., Ehmann, R., Zwirglmaier, K., Drosten, C., & Wendtner, C.
Affiliations: Institut für Mikrobiologie der Bundeswehr (DE)
Charité – Universitätsmedizin Berlin (DE)
München Klinik Schwabing (DE)
University of Cambridge (GB)
LMU Klinikum (DE)
Corresponding author: Drosten, Christian
Wendtner, Clemens
ORCID: Wölfel, Roman
Corman, Victor M.
Seilmaier, Michael
Zange, Sabine
Müller, Marcel A.
Niemeyer, Daniela
Jones, Terry C.
Bleicker, Tobias
Schneider, Julia
Ehmann, Rosina
Zwirglmaier, Katrin
Drosten, Christian
Wendtner, Clemens
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-04-01
Volume: 581
Issue: 7809
Pages: 465-469
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2196-x
OpenAlex: W3013893137
Cited by: 6,661
References: 37
Citations by year: 2026: 92 · 2025: 165 · 2024: 328 · 2023: 526 · 2022: 1091 · 2021: 2228 · 2020: 2219
FWCI: 199.03
Type: journal article
Language: en
Update notices: correction (2020-12-11)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
medRxiv (acceptedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: European Commission (602525)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: COVID-19 pandemic, SARS-CoV-2, upper respiratory tract, viral replication, seroconversion, viral load, hospitalized patients
MeSH terms: Seroconversion, Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Coronavirus Envelope Proteins, Antibodies, Viral, Base Sequence, Blood, Feces, Hospitalization, Humans, Immunoglobulin G, Immunoglobulin M, Lung, Pharynx, Pneumonia, Viral, RNA, Viral, Sputum, Urine, Viral Envelope Proteins, Virus Replication, Virus Shedding, Coronavirus Infections, Clinical Laboratory Techniques, Viral Load, Polymorphism, Single Nucleotide, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Virological assessment of hospitalized patients with COVID-2019

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks